| scholarly article | Q13442814 |
| P50 | author | Harvey M. Friedman | Q89912954 |
| John Capodici | Q108795171 | ||
| Drew Weissman | Q88608402 | ||
| P2093 | author name string | John Lubinski | |
| Katalin Karikò | |||
| Lauren M Hook | |||
| Prakash K Bhuyan | |||
| P2860 | cites work | Micro-RNAs: small is plentiful | Q24672426 |
| RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome | Q27472917 | ||
| RNA interference is mediated by 21- and 22-nucleotide RNAs | Q27860764 | ||
| Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells | Q29547714 | ||
| Synthesis of small RNAs using T7 RNA polymerase | Q29615997 | ||
| ATP requirements and small interfering RNA structure in the RNA interference pathway | Q29618384 | ||
| Activation of the interferon system by short-interfering RNAs | Q29620341 | ||
| Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease | Q33808376 | ||
| Specific interference with gene function by double-stranded RNA in early mouse development | Q33888544 | ||
| Post-transcriptional gene silencing mutants. | Q34041242 | ||
| Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference | Q34146791 | ||
| RNA silencing in plants--defense and counterdefense | Q34292165 | ||
| Herpesvirus entry: an update | Q35217323 | ||
| Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells | Q36626714 | ||
| Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity | Q36829124 | ||
| Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor | Q36955074 | ||
| Inhibition of gammaherpesvirus replication by RNA interference | Q39733511 | ||
| Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action | Q39864233 | ||
| Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. | Q40040178 | ||
| Transcriptional silencing and promoter methylation triggered by double-stranded RNA | Q40370869 | ||
| Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference | Q40695522 | ||
| Short interfering RNA confers intracellular antiviral immunity in human cells | Q40721804 | ||
| siRNA-directed inhibition of HIV-1 infection | Q40727988 | ||
| Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA. | Q41049971 | ||
| The herpes simplex virus-1 glycoprotein E (gE) mediates IgG binding and cell-to-cell spread through distinct gE domains | Q41105435 | ||
| Herpes simplex virus turns off the TAP to evade host immunity | Q41338579 | ||
| Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade | Q41367489 | ||
| Characterization of regions of herpes simplex virus type 1 glycoprotein E involved in binding the Fc domain of monomeric IgG and in forming a complex with glycoprotein I. | Q41389075 | ||
| An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. | Q41462238 | ||
| RNA interference in adult mice. | Q43038702 | ||
| Size constraints for targeting post-transcriptional gene silencing and for RNA-directed methylation in Nicotiana benthamiana using a potato virus X vector | Q43548994 | ||
| The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection | Q45741947 | ||
| Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells | Q45796492 | ||
| Virus Infection of Endothelial Cells | Q45802359 | ||
| Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. | Q45838888 | ||
| A viral inhibitor of peptide transporters for antigen presentation | Q46243412 | ||
| Gene disruptions indicate an essential function for the LmmCRK1 cdc2-related kinase of Leishmania mexicana | Q48058265 | ||
| Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. | Q50723783 | ||
| Induction of an interferon response by RNAi vectors in mammalian cells | Q58235166 | ||
| Double-stranded RNA-binding proteins could suppress RNA interference-mediated antiviral defences | Q73168207 | ||
| Noninvasive gene delivery to the liver by mechanical massage | Q74173511 | ||
| RNA interference targeting Fas protects mice from fulminant hepatitis | Q78961966 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | keratinocyte | Q1473931 |
| Herpes simplex virus type 1 | Q655331 | ||
| P304 | page(s) | 10276-10281 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. | |
| P478 | volume | 78 |
| Q52587809 | A review on current status of antiviral siRNA. |
| Q39139230 | Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication. |
| Q39449202 | Adenovirus-mediated shRNA interference against HSV-1 replication in vitro |
| Q34542419 | Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen |
| Q37914065 | Antiviral RNAi: translating science towards therapeutic success |
| Q40316039 | Antiviral activity of small interfering RNAs: specificity testing using heterologous virus reveals interferon-related effects overlooked by conventional mismatch controls |
| Q42233386 | Cathelicidin antimicrobial peptide LL-37 augments interferon-β expression and antiviral activity induced by double-stranded RNA in keratinocytes |
| Q37639312 | Cutaneous short-interfering RNA therapy. |
| Q33872385 | Decrease of murine cytomegalovirus-induced retinitis by intravenous delivery of immediate early protein-3-specific siRNA. |
| Q83436577 | Effect of siRNAs on HSV-1 plaque formation and relative expression levels of RR mRNA |
| Q35811792 | Enhanced inhibition of Avian leukosis virus subgroup J replication by multi-target miRNAs |
| Q34506213 | Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus |
| Q44759079 | Inhibition of Marek's disease virus replication by retroviral vector-based RNA interference |
| Q45399431 | Inhibition of herpes simplex virus type 1 by small interfering RNA. |
| Q34531744 | Inhibition of viruses by RNA interference |
| Q38977911 | Innate responses to small interfering RNA pools inhibiting herpes simplex virus infection in astrocytoid and epithelial cells |
| Q39489291 | Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes |
| Q36331845 | New therapeutics targets in chronic viral cardiomyopathy. |
| Q35766249 | Optimizing siRNA delivery to the genital mucosa |
| Q36508943 | RNA interference for antiviral therapy |
| Q36440302 | RNA interference: its use as antiviral therapy. |
| Q33560548 | Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach |
| Q36093470 | Silencing viruses by RNA interference |
| Q39704296 | Small interfering RNA against the 2C genomic region of coxsackievirus B3 exerts potential antiviral effects in permissive HeLa cells |
| Q45363703 | Small interfering RNA targeting for infected-cell polypeptide 4 inhibits herpes simplex virus type 1 replication in retinal pigment epithelial cells |
| Q45388986 | Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine |
| Q41951959 | Targeting herpetic keratitis by gene therapy. |
| Q35338935 | The effect of murine cytomegalovirus IE-3 specific shRNA is dependent on intragenic target site due to multiple transcription initiation sites |
| Q33987470 | The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro |
| Q37808542 | Transcriptome and proteome profiling of host responses to Marek's disease virus in chickens |
Search more.